| Glutamatergic mechanisms associated with seizures and epilepsy M Barker-Haliski, HS White Cold Spring Harbor perspectives in medicine 5 (8), a022863, 2015 | 377 | 2015 |
| Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models PH Patra, M Barker‐Haliski, HS White, BJ Whalley, S Glyn, H Sandhu, ... Epilepsia 60 (2), 303-314, 2019 | 137 | 2019 |
| Neuroinflammation in epileptogenesis: insights and translational perspectives from new models of epilepsy ML Barker‐Haliski, W Löscher, HS White, AS Galanopoulou Epilepsia 58, 39-47, 2017 | 100 | 2017 |
| Neuronal injury, gliosis, and glial proliferation in two models of temporal lobe epilepsy JL Loewen, ML Barker-Haliski, EJ Dahle, HS White, KS Wilcox Journal of Neuropathology & Experimental Neurology 75 (4), 366-378, 2016 | 89 | 2016 |
| The GABA synapse as a target for antiepileptic drugs: a historical overview focused on GABA transporters A Schousboe, KK Madsen, ML Barker-Haliski, HS White Neurochemical research 39, 1980-1987, 2014 | 72 | 2014 |
| Validated animal models for antiseizure drug (ASD) discovery: advantages and potential pitfalls in ASD screening M Barker-Haliski, HS White Neuropharmacology 167, 107750, 2020 | 57 | 2020 |
| Validation of a preclinical drug screening platform for pharmacoresistant epilepsy ML Barker-Haliski, K Johnson, P Billingsley, J Huff, LJ Handy, R Khaleel, ... Neurochemical research 42, 1904-1918, 2017 | 54 | 2017 |
| Acute treatment with minocycline, but not valproic acid, improves long‐term behavioral outcomes in the Theiler's virus model of temporal lobe epilepsy ML Barker‐Haliski, TD Heck, EJ Dahle, F Vanegas, TH Pruess, KS Wilcox, ... Epilepsia 57 (12), 1958-1967, 2016 | 50 | 2016 |
| Evaluating an etiologically relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic … ML Barker-Haliski, EJ Dahle, TD Heck, TH Pruess, F Vanegas, KS Wilcox, ... Journal of Pharmacology and Experimental Therapeutics 353 (2), 318-329, 2015 | 44 | 2015 |
| Intravenously administered ganaxolone blocks diazepam-resistant lithium-pilocarpine–induced status epilepticus in rats: comparison with allopregnanolone MS Saporito, JA Gruner, A DiCamillo, R Hinchliffe, M Barker-Haliski, ... Journal of Pharmacology and Experimental Therapeutics 368 (3), 326-337, 2019 | 40 | 2019 |
| Acute cognitive impact of antiseizure drugs in naive rodents and corneal‐kindled mice ML Barker‐Haliski, F Vanegas, MJ Mau, TK Underwood, HS White Epilepsia 57 (9), 1386-1397, 2016 | 38 | 2016 |
| Lamotrigine‐resistant corneal‐kindled mice: a model of pharmacoresistant partial epilepsy for moderate‐throughput drug discovery Z Koneval, KM Knox, HS White, M Barker‐Haliski Epilepsia 59 (6), 1245-1256, 2018 | 37 | 2018 |
| A companion to the preclinical common data elements for pharmacologic studies in animal models of seizures and epilepsy. A Report of the TASK 3 Pharmacology Working Group of … M Barker‐Haliski, LC Harte‐Hargrove, T Ravizza, I Smolders, B Xiao, ... Epilepsia Open 3, 53-68, 2018 | 36 | 2018 |
| What are the arguments for and against rational therapy for epilepsy? M Barker-Haliski, GJ Sills, HS White Issues in clinical epileptology: a view from the bench, 295-308, 2014 | 35 | 2014 |
| Disease modification in epilepsy: from animal models to clinical applications ML Barker-Haliski, D Friedman, JA French, HS White Drugs 75, 749-767, 2015 | 34 | 2015 |
| Alzheimer’s disease and epilepsy: A perspective on the opportunities for overlapping therapeutic innovation L Lehmann, A Lo, KM Knox, M Barker-Haliski Neurochemical research 46 (8), 1895-1912, 2021 | 28 | 2021 |
| Lateral-flow immunoassay for detecting drug-induced inhibition of mitochondrial DNA replication and mtDNA-encoded protein synthesis S Nadanaciva, JH Willis, ML Barker, D Gharaibeh, RA Capaldi, ... Journal of immunological methods 343 (1), 1-12, 2009 | 24 | 2009 |
| Antiseizure drug efficacy and tolerability in established and novel drug discovery seizure models in outbred vs inbred mice Z Koneval, KM Knox, A Memon, DK Zierath, HS White, M Barker‐Haliski Epilepsia 61 (9), 2022-2034, 2020 | 22 | 2020 |
| How clinical development can, and should, inform translational science M Barker-Haliski, D Friedman, HS White, JA French Neuron 84 (3), 582-593, 2014 | 22 | 2014 |
| Expression of the core exon-junction complex factor eukaryotic initiation factor 4A3 is increased during spatial exploration and striatally-mediated learning ML Barker-Haliski, ED Pastuzyn, KA Keefe Neuroscience 226, 51-61, 2012 | 21 | 2012 |
Karen S. WilcoxProfessor of Pharmacology &ToxicologyVerified email at hsc.utah.edu
